This ticker has not been starred yet ILMN Illumina, Inc.
Laboratory Analytical Instruments
Book value per $ invested $ 0.08
Leverage 57.32%
Market Cap $ 33.9B
PE 41.07
Dividend Yield 0.00%
Profit $ 825.0m
Margin 17.61%

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

Subscribe Now For Access - Only $1.99 Per Month